Showing results (1581-1590 of 2,238) with videos related to

Sort By:
Pageof 224
International Journal of Molecular Sciences|August 26, 2022
Potentiality and Inflammatory Marker Expression Are Maintained in Dental Pulp Cell Cultures from Carious TeethShelly Arora, Paul R Cooper, Lara T Friedlander, et al.
Structure (London, England : 1993)|July 28, 2004
The structure of the N-terminal domain of the product of the lissencephaly gene Lis1 and its functional implicationsMyung Hee Kim, David R Cooper, Arkadiusz Oleksy, et al.
Neurotoxicology and Teratology|March 13, 2021
Developmental atrazine exposure in zebrafish produces the same major metabolites as mammals along with altered behavioral outcomesJaniel K Ahkin Chin Tai, Katharine A Horzmann, Jackeline Franco, et al.
The Western Journal of Medicine|March 1, 1984
Seventh-Day Adventist adolescents--life-style patterns and cardiovascular risk factorsR Cooper, A Allen, R Goldberg, et al.
Archives of Disease in Childhood|January 24, 2006
Do children from an inner city British school meet the recommended levels of physical activity? Results from a cross sectional survey using objective measurements of physical activityT Trayers, A R Cooper, C J Riddoch, et al.
Biophysical Journal|March 4, 2009
Quantitative modeling and analysis of the transforming growth factor beta signaling pathwaySeung-Wook Chung, Fayth L Miles, Robert A Sikes, et al.
The American Journal of Pathology|September 8, 2007
Autoimmune dacryoadenitis of NOD/LtJ mice and its subsequent effects on tear protein compositionMáire E Doyle, Lori Boggs, Robert Attia, et al.
Diabetes Care|June 17, 2000
The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled studyM B Grant, R N Mames, C Fitzgerald, et al.
Human Brain Mapping|May 14, 2011
Independent component analysis of DTI reveals multivariate microstructural correlations of white matter in the human brainYi-Ou Li, Fanpei G Yang, Christopher T Nguyen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group BS M Lichtman, D Niedzwiecki, M Barcos, et al.
Pageof 224